Kovacs GG (2017) Tauopathies. Handb Clin Neurol 145:355–368. https://doi.org/10.1016/B978-0-12-802395-2.00025-0

Article  PubMed  Google Scholar 

Holtzman DM, Mandelkow E, Selkoe DJ (2012) Alzheimer disease in 2020. Cold Spring Harb Perspect Med 2(11):a011585. https://doi.org/10.1101/cshperspect.a011585

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guerrero-Muñoz MJ, Gerson J, Castillo-Carranza DL (2015) Tau oligomers: the toxic player at synapses in Alzheimer’s disease. Front Cell Neurosci 9:464. https://doi.org/10.3389/fncel.2015.00464

Article  CAS  PubMed  PubMed Central  Google Scholar 

Niewiadomska G, Niewiadomski W, Steczkowska M, Gasiorowska A (2021) Tau oligomers neurotoxicity. Life (Basel) 11:28. https://doi.org/10.3390/life11010028

Article  CAS  PubMed  Google Scholar 

Chung W-S, Welsh CA, Barres BA, Stevens B (2015) Do glia drive synaptic and cognitive impairment in disease? Nat Neurosci 18:1539–1545. https://doi.org/10.1038/nn.4142

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taddei RN, Perbet R, Mate de Gerando A, Wiedmer AE, Sanchez-Mico M, Connors Stewart T, Gaona A, Melloni A, Amaral AC, Duff K, Frosch MP, Gómez-Isla T (2023) Tau oligomer-containing synapse elimination by microglia and astrocytes in Alzheimer disease. JAMA Neurol 80:1209–1221. https://doi.org/10.1001/jamaneurol.2023.3530

Article  PubMed  PubMed Central  Google Scholar 

Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Sarmiento J, Troncoso J, Jackson GR, Kayed R (2012) Identification of oligomers at early stages of tau aggregation in Alzheimer’s disease. FASEB J 26:1946–1959. https://doi.org/10.1096/fj.11-199851

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cox K, Combs B, Abdelmesih B, Morfini G, Brady ST, Kanaan NM (2016) Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition. Neurobiol Aging 47:113–126. https://doi.org/10.1016/j.neurobiolaging.2016.07.015

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samudra N, Lane-Donovan C, VandeVrede L, Boxer AL (2023) Tau pathology in neurodegenerative disease: Disease mechanisms and therapeutic avenues. J Clin Invest 133:e168553. https://doi.org/10.1172/JCI168553

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mufson EJ, Ward S, Binder L (2014) Prefibrillar tau oligomers in mild cognitive impairment and Alzheimer’s disease. Neurodegener Dis 13:151–153. https://doi.org/10.1159/000353687

Article  CAS  PubMed  Google Scholar 

Vana L, Kanaan NM, Ugwu IC, Wuu J, Mufson EJ, Binder LI (2011) Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer’s disease. Am J Pathol 179:2533–2550. https://doi.org/10.1016/j.ajpath.2011.07.044

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fá M, Puzzo D, Piacentini R, Staniszewski A, Zhang H, Baltrons MA, Li Puma DD, Chatterjee I, Li J, Saeed F, Berman HL, Ripoli C, Gulisano W, Gonzalez J, Tian H, Costa JA, Lopez P, Davidowitz E, Yu WH, Haroutunian V, Brown LM, Palmeri A, Sigurdsson EM, Duff KE, Teich AF, Honig LS, Sierks M, Moe JG, D’Adamio L, Grassi C, Kanaan NM, Fraser PE, Arancio O (2016) Extracellular tau oligomers produce an immediate impairment of LTP and memory. Sci Rep 6:19393. https://doi.org/10.1038/srep19393

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patterson KR, Ward SM, Combs B, Voss K, Kanaan NM, Morfini G, Brady ST, Gamblin TC, Binder LI (2011) Heat shock protein 70 prevents both tau aggregation and the inhibitory effects of preexisting tau aggregates on fast axonal transport. Biochemistry 50:10300–10310. https://doi.org/10.1021/bi2009147

Article  CAS  PubMed  Google Scholar 

Swanson E, Breckenridge L, McMahon L, Som S, McConnell I, Bloom GS (2017) Extracellular tau oligomers induce invasion of endogenous tau into the somatodendritic compartment and axonal transport dysfunction. J Alzheimers Dis 58:803–820. https://doi.org/10.3233/JAD-170168

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alzualde A, Indakoetxea B, Ferrer I, Moreno F, Barandiaran M, Gorostidi A, Estanga A, Ruiz I, Calero M, van Leeuwen FW, Atares B, Juste R, Rodriguez-Martínez AB, López de Munain A (2010) A novel PRNP Y218N mutation in Gerstmann-Sträussler-Scheinker disease with neurofibrillary degeneration. J Neuropathol Exp Neurol 69:789–800. https://doi.org/10.1097/NEN.0b013e3181e85737

Article  CAS  PubMed  Google Scholar 

Hsiao K, Dlouhy SR, Farlow MR, Cass C, Da Costa M, Conneally PM, Hodes ME, Ghetti B, Prusiner SB (1992) Mutant prion proteins in Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles. Nat Genet 1:68–71. https://doi.org/10.1038/ng0492-68

Article  CAS  PubMed  Google Scholar 

Ishizawa K, Komori T, Shimazu T, Yamamoto T, Kitamoto T, Shimazu K, Hirose T (2002) Hyperphosphorylated tau deposition parallels prion protein burden in a case of Gerstmann-Sträussler-Scheinker syndrome P102L mutation complicated with dementia. Acta Neuropathol 104:342–350. https://doi.org/10.1007/s00401-002-0547-3

Article  PubMed  Google Scholar 

Tranchant C, Sergeant N, Wattez A, Mohr M, Warter JM, Delacourte A (1997) Neurofibrillary tangles in Gerstmann-Sträussler-Scheinker syndrome with the A117V prion gene mutation. J Neurol Neurosurg Psychiatry 63:240–246. https://doi.org/10.1136/jnnp.63.2.240

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamazaki M, Oyanagi K, Mori O, Kitamura S, Ohyama M, Terashi A, Kitamoto T, Katayama Y (1999) Variant Gerstmann-Sträussler syndrome with the P105L prion gene mutation: an unusual case with nigral degeneration and widespread neurofibrillary tangles. Acta Neuropathol 98:506–511. https://doi.org/10.1007/s004010051116

Article  CAS  PubMed  Google Scholar 

Gomes LA, Hipp SA, Rijal Upadhaya A, Balakrishnan K, Ospitalieri S, Koper MJ, Largo-Barrientos P, Uytterhoeven V, Reichwald J, Rabe S, Vandenberghe R, von Arnim CAF, Tousseyn T, Feederle R, Giudici C, Willem M, Staufenbiel M, Thal DR (2019) Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein. Acta Neuropathol 138:913–941. https://doi.org/10.1007/s00401-019-02053-5

Article  CAS  PubMed  Google Scholar 

Wang X-F, Dong C-F, Zhang J, Wan Y-Z, Li F, Huang Y-X, Han L, Shan B, Gao C, Han J, Dong X-P (2008) Human tau protein forms complex with PrP and some GSS- and fCJD-related PrP mutants possess stronger binding activities with tau in vitro. Mol Cell Biochem 310:49–55. https://doi.org/10.1007/s11010-007-9664-6

Article  CAS  PubMed  Google Scholar 

Hu N-W, Corbett GT, Moore S, Klyubin I, O’Malley TT, Walsh DM, Livesey FJ, Rowan MJ (2018) Extracellular forms of Aβ and Tau from iPSC models of Alzheimer’s disease disrupt synaptic plasticity. Cell Rep 23:1932–1938. https://doi.org/10.1016/j.celrep.2018.04.040

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ondrejcak T, Klyubin I, Corbett GT, Fraser G, Hong W, Mably AJ, Gardener M, Hammersley J, Perkinton MS, Billinton A, Walsh DM, Rowan MJ (2018) Cellular prion protein mediates the disruption of hippocampal synaptic plasticity by soluble tau in vivo. J Neurosci 38:10595–10606. https://doi.org/10.1523/JNEUROSCI.1700-18.2018

Article  CAS  PubMed  PubMed Central  Google Scholar 

Corbett GT, Wang Z, Hong W, Colom-Cadena M, Rose J, Liao M, Asfaw A, Hall TC, Ding L, DeSousa A, Frosch MP, Collinge J, Harris DA, Perkinton MS, Spires-Jones TL, Young-Pearse TL, Billinton A, Walsh DM (2020) PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins. Acta Neuropathol 139:503–526. https://doi.org/10.1007/s00401-019-02114-9

Article  CAS  PubMed  Google Scholar 

Balducci C, Beeg M, Stravalaci M, Bastone A, Sclip A, Biasini E, Tapella L, Colombo L, Manzoni C, Borsello T, Chiesa R, Gobbi M, Salmona M, Forloni G (2010) Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein. PNAS 107:2295–2300. https://doi.org/10.1073/pnas.0911829107